Get the Stockscreener App
11.14
1.83%
0.20
Beta Bionics Inc stock is traded at $11.14, with a volume of 421.26K.
It is up +1.83% in the last 24 hours and down -32.93% over the past month.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
See More
Previous Close:
$10.94
Open:
$10.95
24h Volume:
421.26K
Relative Volume:
1.12
Market Cap:
$453.43M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.21%
1M Performance:
-32.93%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.63
$11.23
1-Week Range:
$9.76
$11.28
52-Week Range:
$8.89
$24.36
Beta Bionics Inc Stock (BBNX) Company Profile
Name
Beta Bionics Inc
Sector
Industry
Phone
949-427-7785
Address
11 HUGHES, IRVINE
Compare BBNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
11.14 | 453.43M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-25 | Initiated | BofA Securities | Buy |
| Feb-24-25 | Initiated | Lake Street | Buy |
| Feb-24-25 | Initiated | Leerink Partners | Outperform |
| Feb-24-25 | Initiated | Piper Sandler | Overweight |
| Feb-24-25 | Initiated | Stifel | Buy |
| Feb-20-25 | Initiated | Ladenburg Thalmann | Neutral |
| Feb-20-25 | Initiated | Robert W. Baird | Neutral |
View All
Beta Bionics Inc Stock (BBNX) Latest News
Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025 - GlobeNewswire
Beta Bionics, Inc. to Release First Quarter 2025 Financial Results on May 6, 2025 - Nasdaq
Midday Stock Roundup: Boot Barn and El Pollo Loco drops - Orange County Business Journal
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
Beta Bionics to Host Investor Event on June 22, 2025 - The Manila Times
CUBE LAUNCHES REGPLATFORM™ INTEL TO TRANSFORM THE MID-MARKET REGULATORY INTELLIGENCE LANDSCAPE IN FINANCIAL SERVICES - The Globe and Mail
Stifel maintains Buy rating on Beta Bionics stock, target at $25 - Investing.com Canada
SCHD ETF News, 4/2/2025 - The Globe and Mail
Beta Bionics, Inc.: Undervalued Growth Opportunity with Strategic Expansion Plans - TipRanks
Beta Bionics shares ‘too cheap’ with estimates going higher, says BofA - TipRanks
Beta Bionics Explodes to $65.1M in Revenue - Orange County Business Journal
Midday Stock Roundup: Rivian Rises - Orange County Business Journal
Newly public Beta Bionics reports sales surge; Dexcom hires CCO - MedTech Dive
Beta Bionics welcomes new board member Gerard Michel By Investing.com - Investing.com Australia
Beta Bionics appoints new board member from Delcath Systems By Investing.com - Investing.com South Africa
Beta Bionics welcomes new board member Gerard Michel - Investing.com India
Beta Bionics appoints new board member from Delcath Systems - Investing.com India
Beta Bionics Appoints Gerard Michel as Director - TipRanks
Beta Bionics Announces Board Appointment of Gerard Michel - The Manila Times
Stifel maintains Buy on Beta Bionics stock, $25 price target By Investing.com - Investing.com South Africa
Piper Sandler maintains $26 target on Beta Bionics stock By Investing.com - Investing.com Australia
Piper Sandler maintains $26 target on Beta Bionics stock - Investing.com
Stifel maintains Buy on Beta Bionics stock, $25 price target - Investing.com India
Beta Bionics stock surges as Q4 revenue more than doubles - Investing.com Australia
Beta Bionics Reports Strong Growth and Strategic Advances - TipRanks
Beta Bionics Inc (BBNX) Reports Q4 2024 Revenue of $20.4M and Ne - GuruFocus.com
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth - Investing.com Australia
Earnings call transcript: Beta Bionics Q4 2024 sees strong revenue growth By Investing.com - Investing.com South Africa
Beta Bionics stock surges as Q4 revenue more than doubles By Investing.com - Investing.com South Africa
Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025 - The Manila Times
Beta Bionics Announces Fourth Quarter and Full Year 2024 - GlobeNewswire
Mining Stock Catches Early Bid Following Bullish Analyst Shift - The Globe and Mail
Head to Head Survey: Arch Therapeutics (OTCMKTS:ARTH) & Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc.’s Quiet Period Will Expire on March 11th (NASDAQ:BBNX) - Defense World
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
10 Stocks With At Least $10 Million In Insider Spending Recently - Insider Monkey
Beta Bionics Inc Stock (BBNX) Financials Data
There is no financial data for Beta Bionics Inc (BBNX). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):